P3 Health Partners (PIIIW) Competitors $0.01 0.00 (-3.45%) As of 04/17/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock PIIIW vs. ACONW, AONC, DHACW, LFMDP, OTRKP, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak Talkspace Oncology Institute Natera Fresenius Medical Care Hims & Hers Health P3 Health Partners (NASDAQ:PIIIW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, community ranking, media sentiment, analyst recommendations and dividends. Does the media prefer PIIIW or ACONW? In the previous week, P3 Health Partners had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for P3 Health Partners and 0 mentions for Aclarion. P3 Health Partners' average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score. Company Overall Sentiment P3 Health Partners Neutral Aclarion Neutral Does the MarketBeat Community favor PIIIW or ACONW? P3 Health Partners and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformP3 Health PartnersN/AN/AAclarionN/AN/A Which has stronger earnings & valuation, PIIIW or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioP3 Health Partners$1.50BN/AN/AN/AN/AAclarion$45.72KN/AN/AN/AN/A Is PIIIW or ACONW more profitable? Company Net Margins Return on Equity Return on Assets P3 Health PartnersN/A N/A N/A Aclarion N/A N/A N/A SummaryP3 Health Partners beats Aclarion on 2 of the 2 factors compared between the two stocks. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIIIW vs. The Competition Export to ExcelMetricP3 Health PartnersMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.41B$5.31B$7.35BDividend YieldN/A3.83%5.45%4.34%P/E RatioN/A6.8121.9417.82Price / SalesN/A13.45380.6697.73Price / CashN/A12.5138.2534.64Price / BookN/A1.846.453.98Net IncomeN/A$58.65M$3.22B$247.81M7 Day PerformanceN/A2.15%0.74%0.28%1 Month PerformanceN/A-1.70%-9.66%-7.60%1 Year PerformanceN/A9.32%11.81%1.49% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIWP3 Health PartnersN/A$0.01-3.4%N/AN/A$0.00$1.50B0.00500High Trading VolumeACONWAclarionN/A$0.04-9.1%N/A+74.2%$0.00$49,289.000.007AONCAmerican Oncology NetworkN/A$4.61-13.8%N/A+23.0%$0.00$1.34B0.001,520Gap UpDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$22.00-5.6%N/A+8.0%$0.00$212.45M0.00230Gap DownOTRKPOntrakN/A$0.230.0%N/AN/A$0.00$10.84M0.00250TALKWTalkspaceN/A$0.09-21.6%N/A-55.0%$0.00$187.59M0.00500Short Interest ↓Gap DownTOIIWOncology InstituteN/A$0.03+13.2%N/A-87.6%$0.00$393.41M0.00660Short Interest ↑Gap UpNTRANatera3.0041 of 5 stars$151.97+14.9%$178.12+17.2%+73.6%$20.54B$1.70B-86.353,020Positive NewsHigh Trading VolumeFMSFresenius Medical Care3.2374 of 5 stars$23.45+3.9%$25.30+7.9%+21.0%$13.76B$19.34B19.38123,200Positive NewsGap UpHigh Trading VolumeHIMSHims & Hers Health3.7092 of 5 stars$29.39+12.6%$37.31+26.9%+128.9%$6.53B$1.48B66.80650Insider TradeNews CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors LifeMD Competitors Ontrak Competitors Talkspace Competitors Oncology Institute Competitors Natera Competitors Fresenius Medical Care Competitors Hims & Hers Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PIIIW) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
